Kenya National Cancer Control Programme (NCCP) FHIR Implementation Guide, published by Digital Health Agency (DHA), Kenya. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/IntelliSOFT-Consulting/nccpFHIRIG/ and changes regularly. See the Directory of published versions
status: Completed
category: Hormonal Therapy
medication: Tamoxifen
subject: Mary Wanjiku Female, DoB: 1975-06-15
effective: 2018-03-01 --> 2023-02-28
reasonReference: Condition C50 — Malignant neoplasm of breast
note:
Completed 5 years of adjuvant tamoxifen. Switched to letrozole following menopause in 2021.